JWJiqin Wang

Jiqin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiqin Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification of Immune-Related Genes in Sepsis due to Community-Acquired Pneumonia

    by Yanyan Li, Jiqin Wang, Yuzhen Li, Chunyan Liu, Xia Gong, Yifei Zhuang, Liang Chen, Keyu Sun

    Background. Immunosuppression has a key function in sepsis pathogenesis, so it is of great significance to find immune-related markers for the treatment of sepsis. Methods. Datasets of community-acquired pneumonia (CAP) with sepsis from the ArrayExpress database were extracted. Differentially expressed genes (DEGs) between the CAP group and normal group by Limma package were performed. After calculation of immune score through the ESTIMATE algorithm, the DEGs were selected between the high immune score group and the low immune score group. Enrichment analysis of the intersected DEGs was conducted. Further, the protein-protein interaction (PPI) of the intersected DEGs was drawn by Metascape tools. Related publications of the key DEGs were searched in NCBI PubMed through Biopython models, and RT-qPCR was used to verify the expression of key genes. Results. 360 intersected DEGs (157 upregulated and 203 downregulated) were obtained between the two groups. Meanwhile, the intersected DEGs were enriched in 157 immune-related terms. The PPI of the DEGs was performed, and 8 models were obtained. In sepsis-related research, eight genes were obtained with , included in the models. Conclusion. CXCR3, CCR7, HLA-DMA, and GPR18 might participate in the mechanism of CAP with sepsis.


  • Open Access

    SRCIN1 Regulated by circCCDC66/miR‐211 Is Upregulated and Promotes Cell Proliferation in Non‐Small‐Cell Lung Cancer

    by Weijun Hong, Suyun Yu, Yaqing Zhuang, Qingqing Zhang, Jiqin Wang, Xiwen Gao

    The incidence and mortality of lung cancer were extremely high. The present study showed that SRCIN1 was an oncogene in non‐small‐cell lung cancer (NSCLC). Public dataset analysis showed SRCIN1 was significantly overexpressed in NSCLC samples. Also, we found that NSCLC patients with higher SRCIN1 expression had shorter OS time by analyzing TCGA, Kaplan‐Meier Plotter, GSE30219, GSE50081, and GSE19188 databases. Overexpression or knockdown of SRCIN1 significantly induced or reduced A549 and H1299 cell proliferation. Furthermore, we found SRCIN1 was directly targeted by miR‐211. Overexpression or knockdown of miR‐211 suppressed or induced SRCIN1 levels in NSCLC. Moreover, we found that miR‐211 affected NSCLC cell proliferation through SRCIN1. Previous studies demonstrated that circRNAs could act as miRNA sponges in cancer cells. In this study, we showed that knockdown of circCCDC66 induced expression of miR‐211. Luciferase assay demonstrated that miR‐211 suppressed the activity of luciferase reporter‐contained circCCDC66 sequences. Moreover, knockdown of circCCDC66 significantly inhibited SRCIN1 levels in both A549 and H1299 cells. These results showed that circCCDC66 acted as a miRNA sponge to affect the miR‐211/SRCIN1 axis. Of note, we for the first time revealed that circCCDC66 suppression reduced cell proliferation by about 65% in A549 and by about 40% in H1299 cells. We thought this study could provide novel potential biomarkers for NSCLC.